Fitzsimons Innovation Community has been a partner of the Rocky Mountain Life Sciences Investor & Partnering Conference since its inception, recognizing the importance of this gathering to showcase groundbreaking research and innovations in the region. Learn more about the 2022 presenting companies from the Community who share a passion for taking their research to the next level to improve care, cure diseases, and save lives.
Ceria is developing a pipeline of drug products based on a single active agent to treat inflammatory diseases with severe morbidity such as nonhealing wounds, acute lung inflammation, and severe intestinal distress. The company’s core technology addresses these conditions with single-administration drug products that block the underlying cause…
Click here to view original post
